Table 1. Association of CPSF4 expression with patient’s clinicopathological features in human lung adenocarcinoma.

	Total (n = 150)	CPSF4 low expression (n = 99)	CPSF4 high expression (n = 51)	p
Gender
Male	80	50(62.5%)	30(37.5%)	0.333
Female	70	49(70.0%)	21(30.0%)
Age,y
≥60	80	50(62.5%)	30(37.5%)	0.333
<60	70	49(70.0%)	21(30.0%)
pT factor
T1+T2	118	80(67.8%)	38(32.2%)	0.372
T3+T4	32	19(59.4%)	13(40.6%)
pN factor
N0+N1	77	57(74.0%)	20(26.0%)	0.033a
N2+N3	73	42(57.5%)	31(42.5%)

^a P<0.05. Abbreviations: ADC, adenocarcinoma;